Raphael Erez bought DRIO
August 12, 2024 · Form 4 insider transaction
Raphael Erez bought 579 shares of DarioHealth Corp. at $19.10 per share, a transaction worth $11.1K. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 777 days after the transaction.
Footnotes
Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.; The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion.